iRadimed (IRMD) vs SI-BONE (SIBN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
SI-BONE (SIBN) has outperformed iRadimed (IRMD) over the past year, gaining 24.0% versus a gain of 11.7%. Over five years, IRMD leads with a +134.2% price change compared with -17.5% for SIBN. iRadimed is the larger company by market cap ($1.10 billion vs $845.3 million), about 1.3 times the size.
iRadimed pays a dividend yielding 0.90%, while SI-BONE does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | IRMD | SIBN |
|---|---|---|
| Share price | $85.88 | $18.86 |
| Market cap | $1.10B | $845.28M |
| 1-day change | +0.48% | -1.26% |
| YTD return | -11.72% | -4.36% |
| 1-year return | +11.72% | +24.00% |
| 5-year return | +134.20% | -17.46% |
| P/E ratio (TTM) | 47.98 | — |
| Forward P/E | 35.01 | — |
| EPS (TTM) | $1.79 | $-0.34 |
| Dividend yield | 0.90% | 0.00% |
| Annual dividend | $0.77 | $0.00 |
| 52-week high | $107.90 | $21.89 |
| 52-week low | $71.34 | $11.48 |
| Distance from 52-week high | -20.41% | -13.84% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +37.40% | +33.72% |
| Average volume | 125.83K | 543.48K |
| Shares outstanding | 12.79M | 44.82M |
| Employees | 166 | 376 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- SIBN has outperformed IRMD by 12.3 percentage points over the past year.
About iRadimed
IRMD stock →IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; 3880 MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device.
Health Care · Medical/Dental Instruments · 166 employees
About SI-BONE
SIBN stock →SI-BONE, Inc., a medical device company, develops procedural solutions for compromised bone, grounded in expertise in biomechanical design and anatomy-specific applications in the United States and internationally. It offers a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products.
Health Care · Medical/Dental Instruments · 376 employees
IRMD vs SIBN FAQ
Which is bigger, iRadimed or SI-BONE?
iRadimed (IRMD) is larger, with a market capitalization of $1.10B compared with $845.28M for SI-BONE (SIBN).
Which stock has performed better over the past year, IRMD or SIBN?
SIBN returned +24.00% over the past 12 months, compared with +11.72% for IRMD (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, iRadimed or SI-BONE?
iRadimed pays a dividend yielding 0.90%, while SI-BONE does not currently pay a regular dividend.
Are iRadimed and SI-BONE in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.